Clinical Trial Update: Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma [Phase 1, Phase 2]

View source ↗

Summary

This document describes an ongoing Phase 1/Phase 2 clinical trial evaluating a combination of dendritic cell therapy with cytokine-induced killer cells (DCIK) f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• DCIK cells (dendritic cell-activated cytokine-induced killer cells) (dendritic cell-activated cytokine-induced killer cells)
• Dendritic cell therapy

Snippet

Sponsor: Qingdao University | Conditions: Malignant Glioma | Phase 1, Phase 2 | Status: UNKNOWN